Reducing unhealthy alcohol use to improve HIV outcomes
METHODS AND ANALYSIS CORE
This study is looking at how drinking too much alcohol impacts people living with HIV in sub-Saharan Africa and the United States, and it aims to help those individuals by using a special treatment approach to cut down on alcohol and improve their health outcomes.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915738 on NIH RePORTER |
What this research studies
This research investigates how unhealthy alcohol use affects HIV outcomes in sub-Saharan Africa and the United States. It employs a treatment model called the Common Elements Treatment Approach (CETA) to reduce alcohol consumption and enhance clinical results for individuals living with HIV. The study will analyze various factors, including demographics and mental health, to understand how they influence treatment effectiveness. Additionally, it will assess the implementation of alcohol reduction interventions in HIV clinics to support those most in need.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also struggle with unhealthy alcohol consumption.
Not a fit: Patients who do not have HIV or do not engage in unhealthy alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for individuals with HIV by effectively reducing unhealthy alcohol use.
How similar studies have performed: Previous research has shown promising results using similar approaches to address comorbidities in HIV treatment, indicating potential for success in this study.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bosomprah, Samuel — University of Alabama at Birmingham
- Study coordinator: Bosomprah, Samuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.